Literature DB >> 2254014

Immune suppression induced by Actinobacillus actinomycetemcomitans: effects on immunoglobulin production by human B cells.

B J Shenker1, L A Vitale, D A Welham.   

Abstract

Actinobacillus actinomycetemcomitans produces an immunosuppressive factor (ISF) which has been shown to suppress mitogen- and antigen-induced DNA, RNA, and protein synthesis in human T lymphocytes. In this study, we examined purified A. actinomycetemcomitans ISF for its ability to alter immunoglobulin production by human B cells. The ISF caused a dose-dependent inhibition of pokeweed mitogen (PWM)-induced immunoglobulin G (IgG) and IgM production. Preexposure to ISF was not required to achieve maximal inhibition of immunoglobulin synthesis, as previously observed for its effect on T-cell activation. Nevertheless, the ISF appeared to act by irreversibly affecting the early stages of cell activation. While PWM-induced immunoglobulin production is under the influence of T-regulatory circuits, it appears that the ISF interacts directly with B cells. First, ISF failed to alter either the synthesis of interleukin-2 (IL-2) or the expression of IL-2 receptors on T cells. Second, experiments in which individual purified populations of cells were exposed to ISF, washed, and placed back into tissue culture indicated that when all cells (i.e., T cells, B cells, and monocytes) were exposed to ISF, significant suppression was observed. However, when only one cell population was treated with ISF, suppression of both IgG and IgM synthesis was observed only when the B-cell-enriched population was exposed to ISF. These results in conjunction with our earlier findings suggest that the ISF functions via the activation of a regulatory subpopulation of B lymphocytes, which in turn either directly or indirectly (via suppressor T cells) downregulate both B- and T-cell responsiveness. Furthermore, it is hypothesized that patients who harbor A. actinomycetemcomitans could suffer from local or systemic immune suppression. This suppression may enhance the pathogenicity of A. actinomycetemcomitans itself or that of some other opportunistic organism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2254014      PMCID: PMC313746          DOI: 10.1128/iai.58.12.3856-3862.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  Suppression of the immune response by microorganisms.

Authors:  J H Schwab
Journal:  Bacteriol Rev       Date:  1975-06

2.  Suppressor T cells regulating the cell-mediated immune response to Pseudomonas aeruginosa can be generated by immunization with anti-bacterial T cells.

Authors:  R B Markham; G B Pier; W G Powderly
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

3.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Stimulation of regulatory T cell circuits by immunoglobulin-dependent structures on activated B cells.

Authors:  J L'age-Stehr; H Teichmann; R K Gershon; H Cantor
Journal:  Eur J Immunol       Date:  1980-01       Impact factor: 5.532

6.  Suppressor T cells activated by lymphoblastoid cell lines inhibit pokeweed mitogen-induced immunoglobulin synthesis.

Authors:  K Tsukuda; Y Tsukuda; G Klein
Journal:  Cell Immunol       Date:  1981-05-01       Impact factor: 4.868

7.  In vivo responses to inhaled proteins. III. Inhibition of experimental immune complex pneumonitis after suppression of peripheral blood lymphocytes.

Authors:  B J Shenker; W F Willoughby; M R Hollingdale; T N Mann
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

8.  Subacute bacterial endocarditis due to Actinobacillus actinomycetemcomitans.

Authors:  T Hofstad; A Stallemo
Journal:  Scand J Infect Dis       Date:  1981

9.  Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation.

Authors:  Z Metzger; J T Hoffeld; J J Oppenheim
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

10.  Abnormalities of in vitro lymphocyte responses during rubella virus infections.

Authors:  G B Olson; P B Dent; W E Rawls; M A South; J R Montgomery; J L Melnick; R A Good
Journal:  J Exp Med       Date:  1968-07-01       Impact factor: 14.307

View more
  14 in total

1.  A novel factor isolated from Actinobacillus actinomycetemcomitans stimulates mouse B cells and human peripheral blood mononuclear cells.

Authors:  S J Jeong; S T Yee; W S Jo; S H Yu; S H Lee; Y J Lim; Y H Yoo; J M Kim; J D Lee; M H Jeong
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Prevalence of cytolethal distending toxin production in periodontopathogenic bacteria.

Authors:  Ryousuke Yamano; Masaru Ohara; Shuichi Nishikubo; Tamaki Fujiwara; Toru Kawamoto; Yoko Ueno; Hitoshi Komatsuzawa; Katsuji Okuda; Hidemi Kurihara; Hidekazu Suginaka; Eric Oswald; Kazuo Tanne; Motoyuki Sugai
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin.

Authors:  M Sugai; T Kawamoto; S Y Pérès; Y Ueno; H Komatsuzawa; T Fujiwara; H Kurihara; H Suginaka; E Oswald
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

4.  Specific antibody reactivity against a 110-kilodalton Actinobacillus actinomycetemcomitans protein in subjects with periodontitis.

Authors:  T F Fleming; I Selmair; H Schmidt; H Karch
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

5.  Lymphoid susceptibility to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin is dependent upon baseline levels of the signaling lipid, phosphatidylinositol-3,4,5-triphosphate.

Authors:  B J Shenker; L P Walker; A Zekavat; K Boesze-Battaglia
Journal:  Mol Oral Microbiol       Date:  2015-09-24       Impact factor: 3.563

6.  Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle.

Authors:  B J Shenker; S Datar
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

7.  Immunosuppressive effects of Prevotella intermedia on in vitro human lymphocyte activation.

Authors:  B J Shenker; L Vitale; J Slots
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

8.  Immunosuppressive factor from Actinobacillus actinomycetemcomitans down regulates cytokine production.

Authors:  T Kurita-Ochiai; K Ochiai
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Activation of invariant NK T cells in periodontitis lesions.

Authors:  Michael Nowak; Benjamin Krämer; Manuela Haupt; Panos N Papapanou; Justus Kebschull; Per Hoffmann; Ingo G Schmidt-Wolf; Søren Jepsen; Peter Brossart; Sven Perner; Moritz Kebschull
Journal:  J Immunol       Date:  2013-01-30       Impact factor: 5.422

10.  Blockade of the PI-3K signalling pathway by the Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces macrophages to synthesize and secrete pro-inflammatory cytokines.

Authors:  Bruce J Shenker; Lisa P Walker; Ali Zekavat; Mensur Dlakić; Kathleen Boesze-Battaglia
Journal:  Cell Microbiol       Date:  2014-05-01       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.